At Pharma Strategies, we ensure that our clients optimally balance time, risk and cost in order to maximize the potential of a product. Structured, collaborative and data-driven trial designs will position you for clinical and commercial success. Clinical trials are conducted to evaluate the efficacy and safety of medicines and medical devices, and are essential steps in developing effective new medicines and treatments.
It is our observation that Pharma’s innovation focus remains on products and business models, and as such, we are here as Pharma Strategies to construct a compelling list of priorities for our clients in order to improve the company’s innovation performance. We always keep in mind that Innovation performance is a key driver of business performance. Any well-informed investment in innovation will positively impact on your bottom line.
At Pharma Strategies, we combine clinical and commercial insights to transform your product development. Differentiate your product to maximize its long-term success by applying an end-to-end approach characterized by clinical and commercial integration. With Pharma Strategies, you can collaborate with seasoned experts to forge strategies backed by solid data.
Everybody’s talking about market access. But far fewer appear able to define it. In the competitive world of pharmaceutical sales, developing a market access call strategy can pay dividends. As Pharma Strategies, we provide professional advice to our clients on; new pharmaceutical market entry or regional expansion, increasing local market presence, revamping local organizational structures and assessing and implementing new business models in Sub-Sahara Africa.
Developing your business – through partnering, acquisition, licensing – and expanding your portfolio: a big ask in tough economic times. Pharma Strategies can help. Pharmaceutical market intelligence combined with expert scientific pipeline data. Sales forecasts and the latest from conferences. So you can quickly identify companies or compounds of interest around your chosen therapeutic area, including pharma market intelligence, competitive intelligence, IP intelligence, pipeline data, and conference reports.
Pharma Strategies is heavily involved in the provision of Marketing Excellence and Continuous Medical Education “CME” services in the region. We appreciate that our clients face a number of issues of high strategic and financial impact. This is especially true in the areas of launch optimisation, and pricing. We therefore go all out to ensure that the client gets deeper insight into customer needs across multiple demographic segments sub-sahara Africa.